Post a Comment Print Share on Facebook

Minoryx closes a round of 51 million and prepares to enter the commercial phase

The operation, which also includes a bank loan, is co-led by Columbus Ventures Partners and Caixa Capital Risc and has had the participation of Ysios Capital and Fund .

- 6 reads.

Minoryx closes a round of 51 million and prepares to enter the commercial phase

The operation, which also includes a bank loan, is co-led by Columbus Ventures Partners and Caixa Capital Risc and has had the participation of Ysios Capital and Fund .

X-linked adrenoleukodystrophy (X-ALD) is a rare, neurodegenerative and hereditary disease that affects some 20,000 citizens in Europe and for which there is no treatment. The most common form is adrenomyeloneuropathy (AMN).

Avatar
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.